Correlia Biosystems
YC W18San Francisco, US · 16 employees · Inactive · 3 known investors
Correlia Biosystems develops microscale tools for quantifying biomolecules from small blood samples, enabling protein expression monitoring for pharmaceutical research and diagnostics.
Founders & leadership· Y Combinator alumni (W18)
Investors · 3
In the news
- Correlia Biosystems - 2025 Funding Rounds & List of Investors - Tracxntracxn.com · 2021
- Correlia Biosystems Raises $7M in Series A Funding - FinSMEsfinsmes.com · 2020
- Correlia Biosystems Closes $7M Series A to Enable Product Launchprnewswire.com · 2020